These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8192601)

  • 21. [Assessment of the sensitizing potency of cosmetic ingredients and commodities. How will the ingredients of cosmetics and commodities be tested in Europe today and tomorrow?].
    Peiser M; Platzek T; Luch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):373-9. PubMed ID: 22373851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nickel, cobalt and chromium in consumer products: a role in allergic contact dermatitis?
    Basketter DA; Briatico-Vangosa G; Kaestner W; Lally C; Bontinck WJ
    Contact Dermatitis; 1993 Jan; 28(1):15-25. PubMed ID: 8428439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective appraisal of the relationship between skin irritancy and contact sensitization potential.
    Auton TR; Botham PA; Kimber I
    J Toxicol Environ Health; 1995 Oct; 46(2):149-54. PubMed ID: 7563214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative risk assessment of the aggregate dermal exposure to the sensitizing fragrance geraniol in personal care products and household cleaning agents.
    Nijkamp MM; Bokkers BG; Bakker MI; Ezendam J; Delmaar JE
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):9-18. PubMed ID: 26107291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
    Basketter D; Darlenski R; Fluhr JW
    Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citral: identifying a threshold for induction of dermal sensitization.
    Lalko J; Api AM
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):62-73. PubMed ID: 18353514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical load as a factor in skin sensitization risk assessment: rodent versus man.
    Anigbogu AN; Maibach HI
    Contact Dermatitis; 2001 Feb; 44(2):125-6. PubMed ID: 11205398
    [No Abstract]   [Full Text] [Related]  

  • 29. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility study to support a threshold of sensitization concern concept in risk assessment based on human data.
    Keller D; Krauledat M; Scheel J
    Arch Toxicol; 2009 Dec; 83(12):1049-60. PubMed ID: 19680631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupational hand eczema caused by nickel and evaluated by quantitative exposure assessment.
    Jensen P; Thyssen JP; Johansen JD; Skare L; Menné T; Lidén C
    Contact Dermatitis; 2011 Jan; 64(1):32-6. PubMed ID: 21166816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin sensitisation.
    Basketter D; Casati S; Gerberick GF; Griem P; Philips B; Worth A
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():83-103. PubMed ID: 16194142
    [No Abstract]   [Full Text] [Related]  

  • 33. Skin sensitization risk assessment: a comparative evaluation of 3 isothiazolinone biocides.
    Basketter DA; Rodford R; Kimber I; Smith I; Wahlberg JE
    Contact Dermatitis; 1999 Mar; 40(3):150-4. PubMed ID: 10073443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergic contact dermatitis caused by farnesol: clinical relevance.
    Gilpin S; Maibach H
    Cutan Ocul Toxicol; 2010 Dec; 29(4):278-87. PubMed ID: 20858058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience.
    Taylor JS; Praditsuwan P; Handel D; Kuffner G
    Arch Dermatol; 1996 May; 132(5):515-8. PubMed ID: 8624147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative risk assessment for the induction of allergic contact dermatitis: uncertainty factors for mucosal exposures.
    Farage MA; Bjerke DL; Mahony C; Blackburn KL; Gerberick GF
    Contact Dermatitis; 2003 Sep; 49(3):140-7. PubMed ID: 14678210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patch tests versus use tests in skin irritation risk assessment.
    Basketter D; Gilpin G; Kuhn M; Lawrence D; Reynolds F; Whittle E
    Contact Dermatitis; 1998 Nov; 39(5):252-6. PubMed ID: 9840263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The multiple factors affecting the association between atopic dermatitis and contact sensitization.
    Thyssen JP; McFadden JP; Kimber I
    Allergy; 2014 Jan; 69(1):28-36. PubMed ID: 24372195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin Sensitization: Challenging the Conventional Thinking-A Case Against 2 Out of 3 as Integrated Testing Strategy.
    Johansson H; Gradin R
    Toxicol Sci; 2017 Sep; 159(1):3-5. PubMed ID: 28633468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.